Nasdaq Grcl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) has received an average recommendation of “Hold” from the eight brokerages that are presently covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokerages […]

Shares of Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report) have earned an average recommendation of “Hold” from the eight ratings firms that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price objective […]

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ:...

Gracell Biotechnologies Inc. (NASDAQ:GRCL – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $10.22 and last traded at $10.21, with a volume of 474243 shares traded. The stock had previously closed at $10.18. Wall Street Analysts Forecast Growth Several research firms […]

Several brokerages have updated their recommendations and price targets on shares of Gracell Biotechnologies (NASDAQ: GRCL) in the last few weeks: 12/27/2023 – Gracell Biotechnologies had its “neutral” rating reaffirmed by analysts at Piper Sandler. They now have a $10.00 price target on the stock. 12/27/2023 – Gracell Biotechnologies had its “equal weight” rating reaffirmed […]